Our Pricing

Understanding the Wegovy Price Increase in the UK: What Patients Need to Know

The Wegovy price increase UK has prompted many patients to seek transparent, competitive pricing for this MHRA-licensed semaglutide weight loss injection. Following manufacturer adjustments and supply chain factors throughout 2024, UK pharmacies have updated their pricing structures, making it essential for patients to compare costs and understand what they're paying for. At Cured Pharmacy, we maintain the cheapest UK price from £69.00, with £20 off your first order using code Weightlossnew, ensuring you receive genuine, UK-licensed Wegovy without hidden fees.

What Caused the Wegovy Price Increase UK Patients Are Seeing?

The Wegovy price increase UK pharmacies implemented in 2024 stems from multiple factors including manufacturer pricing adjustments by Novo Nordisk, increased demand following NICE approval for NHS prescription in certain BMI categories, and supply chain pressures affecting GLP-1 medications globally [1]. Unlike sudden price hikes, these changes occurred gradually as the medication transitioned from limited availability to wider UK market access.

As a UK-registered pharmacy (GPhC 9012511), we've monitored these pricing shifts closely under the guidance of our superintendent pharmacist Tarun Kumar (GPhC 2233073). While some UK pharmacies now charge upwards of £69.00-£69.00 per month for Wegovy, Cured Pharmacy has maintained competitive pricing at £69.00 per dose, reflecting our commitment to accessible weight management treatment. This price includes your medication, UK prescriber consultation, and discreet next-day delivery across England, Scotland, Wales, and Northern Ireland.

The price variations across UK pharmacies often reflect differences in service models rather than medication quality—all legitimate UK pharmacies dispense the same MHRA-licensed Wegovy. Understanding what's included in your price (consultation fees, delivery, ongoing support) helps you identify genuine value beyond the headline cost [2].

How the Wegovy Price Increase UK Affects Your Weight Loss Budget

Planning for the Wegovy price increase UK requires understanding the full treatment timeline. Wegovy follows a structured dose escalation over 16-20 weeks, starting at 0.25mg weekly and building to the maintenance dose of 2.4mg weekly [3]. Each pen contains four weekly doses, meaning you'll need one pen per month during maintenance therapy.

At Cured Pharmacy's price of £69.00 per pen, a typical patient's annual cost for Wegovy sits around £69.00 once reaching maintenance dosing—significantly lower than many UK competitors charging £69.00-£69.00 monthly. Using code Weightlossnew saves you an additional £69.00 on your first order, reducing your initial month's cost to £69.00. This transparent pricing model means no surprise consultation fees or hidden delivery charges.

Budgeting for Long-Term Wegovy Treatment

Clinical trials including the STEP programme demonstrated that semaglutide 2.4mg produced average weight loss of 15-17% of body weight over 68 weeks when combined with lifestyle modifications [4]. Most patients require 12-18 months of treatment to achieve and consolidate their weight loss goals, making cost predictability essential. Our fixed pricing structure at £69.00 per pen allows you to budget accurately without worrying about mid-treatment price increases that some pharmacies implement.

Comparing Wegovy Price Increase UK Across Pharmacy Options

When evaluating the Wegovy price increase UK pharmacies have introduced, comparing like-for-like services matters more than headline prices alone. Some online pharmacies advertise lower initial prices but add consultation fees (£69.00-£69.00), delivery charges (£69.00-£69.00), or subscription lock-ins that increase your total cost significantly.

Cured Pharmacy's £69.00 price includes your complete service: a thorough clinical assessment by UK-registered prescribers, genuine MHRA-licensed Wegovy sourced directly from licensed wholesalers, discreet packaging, and next-day delivery at no additional charge. Our medical team reviews your health history, current medications, and weight loss goals during a consultation that typically takes under three minutes to complete online.

Price transparency extends to our dose options—whether you're starting at 0.25mg or continuing at 2.4mg maintenance, the per-pen price remains consistent at £69.00. This differs from tiered pricing models some pharmacies use, where higher doses cost disproportionately more despite containing the same monthly supply [5].

Why Wegovy Price Increase UK Hasn't Affected Cured Pharmacy Rates

Despite the broader Wegovy price increase UK trends, Cured Pharmacy has maintained stable pricing through strategic supplier relationships and operational efficiency. As a fully digital pharmacy, we avoid the overhead costs of physical premises that traditional pharmacies pass to customers, allowing us to offer the cheapest UK price without compromising on clinical standards or medication authenticity.

Our GPhC registration (9012511) and superintendent pharmacist oversight ensure every Wegovy pen dispensed meets the same rigorous standards as any high-street pharmacy. We source exclusively from UK-licensed wholesalers, with full cold-chain management to maintain semaglutide's stability from warehouse to your door. This commitment to quality at £69.00 per pen represents exceptional value in the current UK market.

How We Keep Wegovy Affordable

Our pricing model prioritises volume efficiency and patient retention over per-transaction margins. By streamlining the prescription process through our digital platform and maintaining direct supplier relationships, we eliminate intermediary costs that inflate prices elsewhere. The £20 discount on first orders (code Weightlossnew) further demonstrates our commitment to accessible weight loss treatment, particularly as patients navigate the initial investment in their health journey [6].

Understanding What You Get Despite the Wegovy Price Increase UK

The Wegovy price increase UK hasn't diminished the clinical value this medication offers eligible patients. Semaglutide 2.4mg remains the most extensively studied GLP-1 receptor agonist for weight management, with STEP trial data showing sustained weight loss averaging 15.3kg over 68 weeks in patients with obesity [7]. These results, achieved when Wegovy is combined with reduced-calorie diet and increased physical activity, represent clinically significant improvements in weight-related health markers.

At Cured Pharmacy's price point of £69.00 monthly, you're accessing the same pharmaceutical-grade semaglutide used in these landmark trials, dispensed under UK prescriber supervision with ongoing clinical support. Each pen contains precisely measured doses with Novo Nordisk's FlexTouch delivery system, designed for subcutaneous self-administration once weekly. The medication's efficacy doesn't correlate with price—whether you pay £69.00 or £69.00 the active ingredient and clinical outcomes remain identical, subject to individual response and adherence.

Navigating the Wegovy Price Increase UK: Your Next Steps

If you're concerned about the Wegovy price increase UK and seeking affordable access to this prescription weight loss treatment, Cured Pharmacy offers a straightforward pathway. Our online consultation takes under three minutes and covers your medical history, current health status, weight loss goals, and any contraindications to semaglutide therapy. UK-registered prescribers review your assessment typically within hours, and approved prescriptions are dispensed the same working day for next-day delivery.

Starting at £69.00 per pen with an additional £20 off using code Weightlossnew, your first month costs just £69.00—among the most competitive rates in the UK market. This includes all consultations, the medication itself, and delivery, with no hidden fees or subscription requirements. You control your treatment timeline, ordering as needed without pressure to commit to long-term contracts that lock you into potentially increasing prices.

Getting Started with Wegovy at Cured Pharmacy

Begin your weight loss journey by completing our clinical questionnaire, which ensures Wegovy is safe and appropriate for your individual circumstances. Our prescribers assess factors including your BMI, previous weight loss attempts, co-existing conditions like type 2 diabetes or cardiovascular disease, and current medications that might interact with semaglutide [8]. If approved, your Wegovy ships in discreet packaging with full administration instructions and ongoing access to our pharmacy team for questions throughout your treatment. With transparent pricing at £69.00 per pen, you can focus on your health goals rather than worrying about fluctuating costs.

Scientific References

1. Novo Nordisk. (2024). Wegovy (semaglutide) injection: Prescribing information. Novo Nordisk A/S. [accessed 15 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4mg solution for injection in pre-filled pen: Summary of product characteristics. MHRA. [accessed 15 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
5. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
7. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: The STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
8. Royal Pharmaceutical Society. (2023). Professional guidance on the supply of GLP-1 receptor agonists for weight management. RPS. [accessed 15 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.